nevirapine has been researched along with Cytomegalic Inclusion Disease in 3 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As of September 1, 1996, ADAP began covering HIV protease inhibitors, viral load evaluations, and other crucial anti-HIV and opportunistic infection agents, including nevirapine for HIV, cidofovir for CMV, and DaunoXome for Kaposi's sarcoma." | 3.69 | New York ADAP to cover new AIDS drugs plus viral load testing. ( Link, D, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manicklal, S | 1 |
| van Niekerk, AM | 1 |
| Kroon, SM | 1 |
| Hutto, C | 1 |
| Novak, Z | 1 |
| Pati, SK | 1 |
| Chowdhury, N | 1 |
| Hsiao, NY | 1 |
| Boppana, SB | 1 |
| Kourtis, AP | 1 |
| Wiener, J | 1 |
| Chang, TS | 1 |
| Dollard, SC | 1 |
| Amin, MM | 1 |
| Ellington, S | 1 |
| Kayira, D | 1 |
| van der Horst, C | 1 |
| Jamieson, DJ | 1 |
| Link, D | 1 |
1 trial available for nevirapine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Cytomegalovirus IgG Level and Avidity in Breastfeeding Infants of HIV-Infected Mothers in Malawi.
Topics: Anti-HIV Agents; Antibodies, Viral; Antibody Affinity; Breast Feeding; Cytomegalovirus; Cytomegalovi | 2015 |
2 other studies available for nevirapine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active | 2014 |
New York ADAP to cover new AIDS drugs plus viral load testing.
Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antiviral Agents; Cytomegalovirus I | 1996 |